You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Type 2 Inflammation

Role of Type 2 Cytokines in Asthma and COPD

Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.
Mario Castro
MD, MPH
Mario Castro

Learning objectives

  • Understand the role of type 2 cytokines in driving type 2 inflammation and airway remodeling in asthma and COPD
  • Recognize the impact of targeting type 2 inflammation on patient symptoms in both, asthma and COPD

Description

The video discusses how type 2 inflammation contributes to airway remodeling and inflammation in asthma and COPD, inhibition of type 2 inflammation could improve patient outcomes in asthma and COPD.

Tags
IL-4IL-5IL-13cytokinesairway remodelingasthmaCOPDtype 2 inflammation
MAT-GLB-2500894 - 1.0 - 04/2025

About this expert

Pulmonology

Mario Castro

MD, MPH

Chief, Pulmonary, Critical Care and Sleep Medicine; Vice Chair for Clinical and Translational Research, University of Kansas School of Medicine

See author’s profile
Mario Castro

Related resources

ERS 2023 | Adult Asthma Symposium: Mini Debate
Pulmonology
expert video

ERS 2023 | Adult Asthma Symposium: Mini Debate

ERS 2023 | Adult Asthma Symposium: Panel Discussion
Pulmonology
expert video

ERS 2023 | Adult Asthma Symposium: Panel Discussion

ERS 2023 | Advancing Asthma Management Beyond Control
Pulmonology
expert video

ERS 2023 | Advancing Asthma Management Beyond Control

ERS 2023 | Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
Pulmonology
expert video

ERS 2023 | Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma

ERS 2023 | Burden of Underlying Disease in Pediatric Severe Asthma
Pulmonology
expert video

ERS 2023 | Burden of Underlying Disease in Pediatric Severe Asthma

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
Pulmonology
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?
Pulmonology
expert video

ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?

ERS 2023 | On-Therapy Remission in Pediatric Asthma: Where Are We Today?
Pulmonology
expert video

ERS 2023 | On-Therapy Remission in Pediatric Asthma: Where Are We Today?

ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion
Pulmonology
expert video

ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion

ERS 2023 | Progression of Underlying Disease in Pediatric Severe Asthma
Pulmonology
expert video

ERS 2023 | Progression of Underlying Disease in Pediatric Severe Asthma

ERS 2023 | Type 2 Biomarkers as Predictive and Prognostic Tools to Guide Management
Pulmonology
expert video

ERS 2023 | Type 2 Biomarkers as Predictive and Prognostic Tools to Guide Management

How Can Biologics Improve Lung Function in Pediatric Severe Asthma?
Pulmonology
expert video

How Can Biologics Improve Lung Function in Pediatric Severe Asthma?

GINA Asthma Decision Tree
Pulmonology
videoanimation

GINA Asthma Decision Tree

Type 2 Inflammation as the Common Thread in Multiple Diseases
Type 2 Inflammation
videoanimation

Type 2 Inflammation as the Common Thread in Multiple Diseases

EAACI 2023 | Pediatric Severe Asthma: Why Lung Function Matters
Pulmonology
expert video

EAACI 2023 | Pediatric Severe Asthma: Why Lung Function Matters

EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression
Type 2 Inflammation
expert video

EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients
Type 2 Inflammation
expert video

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients

Understanding the Pathophysiology of Pediatric Type 2 Inflammatory Diseases
Type 2 Inflammation
expert video

Understanding the Pathophysiology of Pediatric Type 2 Inflammatory Diseases

Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis
Type 2 Inflammation
expert video

Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis

Multidisciplinary Partnership for Type 2 Inflammatory Diseases
Type 2 Inflammation
expert video

Multidisciplinary Partnership for Type 2 Inflammatory Diseases

Asthma White Board Video
Pulmonology
videoanimation

Asthma White Board Video

Type 2 Inflammation Underpins Pediatric Severe Asthma
Pulmonology
Infographic

Type 2 Inflammation Underpins Pediatric Severe Asthma

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?
Pulmonology
expert video

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age
Pulmonology
interactivity

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

Role of Type 2 Inflammation in Skin Barrier Dysfunction in AD
Type 2 Inflammation
expert video

Role of Type 2 Inflammation in Skin Barrier Dysfunction in AD

GOLD 2024 Diagnosis and Assessment of COPD
Pulmonology
expert video

GOLD 2024 Diagnosis and Assessment of COPD

Importance of Lung Function Assessment in Pediatric Asthma Patients
Pulmonology
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?
Pulmonology
Podcast

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care
Pulmonology
videoanimation

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?
Pulmonology
videoanimation

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?

Role of Type 2 Inflammation Across Different Chronic Diseases
Type 2 Inflammation
expert video

Role of Type 2 Inflammation Across Different Chronic Diseases

Trajectories of Type 2 Inflammation in Pediatric Patients
Type 2 Inflammation
expert video

Trajectories of Type 2 Inflammation in Pediatric Patients

Evolving Topics in Type 2 Inflammation
Type 2 Inflammation
expert video

Evolving Topics in Type 2 Inflammation

Connecting the Dots from Type 2 Inflammation to Patient Perspectives
Type 2 Inflammation
expert video

Connecting the Dots from Type 2 Inflammation to Patient Perspectives

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission
Pulmonology
expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

EAACI 2024 Emerging Definitions of Clinical Remission and Achieving Clinical Remission With Biologics for Patients With Asthma
Pulmonology
expert video

EAACI 2024 Emerging Definitions of Clinical Remission and Achieving Clinical Remission With Biologics for Patients With Asthma

EAACI 2024 Evolving Perspectives in CRSwNP Patient Care
Pulmonology
expert video

EAACI 2024 Evolving Perspectives in CRSwNP Patient Care

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Eosinophils as a Biomarker for Type 2 Asthma
Pulmonology
expert video

Eosinophils as a Biomarker for Type 2 Asthma

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
Pulmonology
expert video

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13

ERS 2024 | Understanding the Complex Pathophysiology of COPD
Pulmonology
expert video

ERS 2024 | Understanding the Complex Pathophysiology of COPD

COPD and Asthma: What's the Difference and Is There a Link?
Pulmonology
interactivity

COPD and Asthma: What's the Difference and Is There a Link?

Type 2 Inflammation Digital Assessment Tool
Pulmonology
interactivity

Type 2 Inflammation Digital Assessment Tool

ADVENT On Air | Common Drivers of Type 2 Inflammatory Diseases
Type 2 Inflammation
Podcast

ADVENT On Air | Common Drivers of Type 2 Inflammatory Diseases

On-Treatment Asthma Remission: Moving Beyond Control
Pulmonology
interactivity

On-Treatment Asthma Remission: Moving Beyond Control

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology
Pulmonology
expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD
Pulmonology
expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features
Pulmonology
expert video

GOLD 2023 | Role of Underlying Inflammation in COPD Pathology and Clinical Features

What Are the Key Inflammatory Processes in Patients with COPD?
Pulmonology
expert video

What Are the Key Inflammatory Processes in Patients with COPD?

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: DenmarkChange country/region